Immunosuppressants – Mechanistic and Pharmacological Characterization of IGF1R kinase inhibitor

Activation of the platelets with TRAP-6 (which stimulates PAR-1) and the PMNs with C5a (which stimulates the C5a receptor and up-regulates surface CD11b) triggered formation of PPC

October 21, 2021 sdfca

Activation of the platelets with TRAP-6 (which stimulates PAR-1) and the PMNs with C5a (which stimulates the C5a receptor and up-regulates surface CD11b) triggered formation

Category: Immunosuppressants

﻿Activation of the platelets with TRAP-6 (which stimulates PAR-1) and the PMNs with C5a (which stimulates the C5a receptor and up-regulates surface CD11b) triggered formation of PPC

Activation of the platelets with TRAP-6 (which stimulates PAR-1) and the PMNs with C5a (which stimulates the C5a receptor and up-regulates surface CD11b) triggered formation of PPC